Skip to main content
Top
Published in: Journal of General Internal Medicine 7/2016

01-07-2016 | Clinical Practice: Exercises in Clinical Reasoning

When the Illness Goes Off Script—An Exercise in Clinical Reasoning

Authors: Georges Al-Helou, M.D., Zafia Anklesaria, M.D., Jeffrey Kohlwes, M.D., M.P.H., Jalil Ahari, M.D., Gurpreet Dhaliwal, M.D.

Published in: Journal of General Internal Medicine | Issue 7/2016

Login to get access

Excerpt

In this series, a clinician extemporaneously discusses the diagnostic approach (regular text) to sequentially presented clinical information (bold). Additional commentary on the diagnostic reasoning process (italics) is integrated throughout the discussion. …
Literature
1.
4.
go back to reference Edelweiss M, Medeiros LJ, Suster S, Moran CA. Lymph node involvement by Langerhans cell histiocytosis: a clinicopathologic and immunohistochemical study of 20 cases. Hum Pathol. 2007;38(10):1463–1469.CrossRefPubMed Edelweiss M, Medeiros LJ, Suster S, Moran CA. Lymph node involvement by Langerhans cell histiocytosis: a clinicopathologic and immunohistochemical study of 20 cases. Hum Pathol. 2007;38(10):1463–1469.CrossRefPubMed
5.
go back to reference Ramos-Casals M, Brito-Zerón P, López-Guillermo A, et al. Adult haemophagocytic syndrome. Lancet. 2014;383(9927):1503–1516.CrossRefPubMed Ramos-Casals M, Brito-Zerón P, López-Guillermo A, et al. Adult haemophagocytic syndrome. Lancet. 2014;383(9927):1503–1516.CrossRefPubMed
6.
go back to reference Aricò M, Girschikofsky M, Généreau T, et al. Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Eur J Cancer. 2003;39(16):2341–2348.CrossRefPubMed Aricò M, Girschikofsky M, Généreau T, et al. Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Eur J Cancer. 2003;39(16):2341–2348.CrossRefPubMed
7.
go back to reference Broadbent V, Egeler RM, Nesbit ME. Langerhans cell histiocytosis—clinical and epidemiological aspects. Br J Cancer Suppl. 1994;23:S11–S16.PubMedPubMedCentral Broadbent V, Egeler RM, Nesbit ME. Langerhans cell histiocytosis—clinical and epidemiological aspects. Br J Cancer Suppl. 1994;23:S11–S16.PubMedPubMedCentral
8.
go back to reference Allen CE, Li L, Peters TL, et al. Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells. J Immunol. 2010;184(8):4557–4567.CrossRefPubMedPubMedCentral Allen CE, Li L, Peters TL, et al. Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells. J Immunol. 2010;184(8):4557–4567.CrossRefPubMedPubMedCentral
9.
go back to reference Favara BE, Jaffe R, Egeler RM. Macrophage activation and hemophagocytic syndrome in langerhans cell histiocytosis: report of 30 cases. Pediatr Dev Pathol. 2002;5(2):130–140.CrossRefPubMed Favara BE, Jaffe R, Egeler RM. Macrophage activation and hemophagocytic syndrome in langerhans cell histiocytosis: report of 30 cases. Pediatr Dev Pathol. 2002;5(2):130–140.CrossRefPubMed
Metadata
Title
When the Illness Goes Off Script—An Exercise in Clinical Reasoning
Authors
Georges Al-Helou, M.D.
Zafia Anklesaria, M.D.
Jeffrey Kohlwes, M.D., M.P.H.
Jalil Ahari, M.D.
Gurpreet Dhaliwal, M.D.
Publication date
01-07-2016
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 7/2016
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-016-3632-3

Other articles of this Issue 7/2016

Journal of General Internal Medicine 7/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.